Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-55,600
Closed -$1.85M 604
2023
Q1
$1.85M Buy
55,600
+16,700
+43% +$641K 0.05% 507
2022
Q4
$1.19M Buy
38,900
+26,400
+211% +$833K 0.04% 542
2022
Q3
$428K Sell
12,500
-31,400
-72% -$1.34M 0.01% 549
2022
Q2
$1.52M Buy
+43,900
New +$1.55M 0.04% 523
2021
Q4
$2M Buy
31,900
+25,700
+415% +$2.18M 0.04% 505
2021
Q3
$653K Hold
6,200
0.01% 587
2021
Q2
$1.1M Buy
6,200
+1,500
+32% +$241K 0.02% 580
2021
Q1
$627K Sell
4,700
-5,300
-53% -$821K 0.01% 575
2020
Q4
$1.35M Buy
10,000
+4,500
+82% +$458K 0.03% 576
2020
Q3
$457K Buy
+5,500
New +$442K 0.01% 609

Other funds holding ZLAB

Andra AP-fonden's ZLAB Position: Q2 2023 in Review

Andra AP-fonden sold out of Zai Lab (ZLAB) in Q2 2023, closing a stake of 55,600 shares — an estimated $1.85M sold.

Andra AP-fonden first reported a position in ZLAB in Q3 2020 and held it in 10 quarters. The position peaked at $2M in Q4 2021. 137 funds tracked by Wall St. Rank hold ZLAB as of Q2 2023.

  • Andra AP-fonden reported no remaining Zai Lab position as of Q2 2023 after selling out during the quarter.
  • Andra AP-fonden sold 55,600 Zai Lab shares in Q2 2023, an estimated $1.85M.
  • Andra AP-fonden first reported a position in Zai Lab in Q3 2020 and held it in 10 quarters.
  • Andra AP-fonden's Zai Lab position peaked at $2M in Q4 2021.
  • 137 funds tracked by Wall St. Rank held Zai Lab as of Q2 2023.

Based on Andra AP-fonden's 13F filing for Q2 2023, filed 9 Aug 2023.